{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:22:14Z","timestamp":1790392934863,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T00:00:00Z","timestamp":1542758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T00:00:00Z","timestamp":1542758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Ministry of Economy and Competitiveness | Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FIS PI14\/00265"],"award-info":[{"award-number":["FIS PI14\/00265"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Ministry of Economy and Competitiveness | Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI14\/00265"],"award-info":[{"award-number":["PI14\/00265"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Ministry of Economy and Competitiveness | Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI14\/00265"],"award-info":[{"award-number":["PI14\/00265"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Ministry of Economy and Competitiveness | Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI14\/00265"],"award-info":[{"award-number":["PI14\/00265"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"Fondo Europeo de Desarrollo Regional","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Common variable immunodeficiency (CVID) is characterized by an abnormal B cell differentiation to memory and antibody-secreting B cells. The defective functionality of CVID patients\u2019 B cells could be the consequence of alterations in apoptosis regulation. We studied the balance of Bcl-2 family anti-\/pro-apoptotic proteins to identify molecular mechanisms that could underlie B cell survival defects in CVID. We used flow cytometry to investigate Bcl-2, Bcl-XL, Bax, and Bim expression in B cells ex vivo and after anti-CD40 or anti-BCR activation with or without IL-21, besides to spontaneous and stimulation-induced Caspase-3 activation and viable\/apoptotic B cell subpopulations. We found increased basal levels of Bax and Bim in CVID B cells that correlated with low viability and high Caspase-3 activation only in CD27<jats:sup>+<\/jats:sup> B cells, particularly in a subgroup of apoptosis-prone CVID (AP-CVID) patients with low peripheral B cell counts and high autoimmunity prevalence (mostly cytopenias). We detected a broad B cell defect in CVID regarding Bcl-2 and Bcl-XL induction, irrespective of the stimulus used. Therefore, peripheral CVID memory B cells are prompted to die from apoptosis due to a constitutive Bcl-2 family protein imbalance and defective protection from activation-induced apoptosis. Interestingly, anti-CD40 and IL-21 induced normal and even higher levels of Bcl-XL, respectively, in CD27<jats:sup>+<\/jats:sup> B cells from AP-CVID, which was accompanied by cell viability increase. Thus low-survival memory B cells from AP-CVID can overcome their cell death regulation defects through pro-survival signals provided by T cells. In conclusion, we identify apoptosis regulation defects as disease-contributing factors in CVID. B cell counts and case history of cytopenias might be useful to predict positive responses to therapeutic approaches targeting T-dependent signaling pathways.<\/jats:p>","DOI":"10.1038\/s41419-018-1191-8","type":"journal-article","created":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T09:52:53Z","timestamp":1542793973000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["IL-21 and anti-CD40 restore Bcl-2 family protein imbalance in vitro in low-survival CD27+ B cells from CVID patients"],"prefix":"10.1038","volume":"9","author":[{"given":"Antonio","family":"L\u00f3pez-G\u00f3mez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Clemente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanesa","family":"Cunill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Pons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana M.","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,21]]},"reference":[{"key":"1191_CR1","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/ar4032","volume":"14","author":"U Salzer","year":"2012","unstructured":"Salzer, U., Warnatz, K. & Peter, H. H. Common variable immunodeficiency \u2013 an update. Arthritis Res. Ther. 14, 223 (2012).","journal-title":"Arthritis Res. Ther."},{"key":"1191_CR2","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/j.1365-2249.2007.03432.x","volume":"149","author":"P Wood","year":"2007","unstructured":"Wood, P. et al. Recognition, clinical diagnosis and management of patients with primary antibody deficiencies: a systematic review. Clin. Exp. Immunol. 149, 410\u2013423 (2007).","journal-title":"Clin. Exp. Immunol."},{"key":"1191_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1749-6632.2011.06377.x","volume":"1250","author":"U Salzer","year":"2012","unstructured":"Salzer, U., Unger, S. & Warnatz, K. Common variable immunodeficiency (CVID): exploring the multiple dimensions of a heterogeneous disease. Ann. NY Acad. Sci. 1250, 41 (2012).","journal-title":"Ann. NY Acad. Sci."},{"key":"1191_CR4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/B978-0-12-385991-4.00002-7","volume":"111","author":"PF Yong","year":"2011","unstructured":"Yong, P. F., Thaventhiran, J. E. & Grimbacher, B. \u201cA rose is a rose is a rose,\u201d but CVID is not CVID common variable immune deficiency (CVID), what do we know in 2011? Adv. Immunol. 111, 47\u2013107 (2011).","journal-title":"Adv. Immunol."},{"key":"1191_CR5","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1023\/A:1025373601374","volume":"23","author":"B Piqueras","year":"2003","unstructured":"Piqueras, B. et al. Common variable immunodeficiency patient classification based on impaired B-cell memory differentiation correlates with clinical aspects. J. Clin. Immunol. 23, 385\u2013400 (2003).","journal-title":"J. Clin. Immunol."},{"key":"1191_CR6","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1182\/blood.V99.5.1544","volume":"99","author":"K Warnatz","year":"2002","unstructured":"Warnatz, K. et al. Severe deficiency of switched memory B-cells (CD27(+)IgM(\u2013)IgD(\u2013)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood 99, 1544\u20131551 (2002).","journal-title":"Blood"},{"key":"1191_CR7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1182\/blood-2007-06-091744","volume":"111","author":"C Wehr","year":"2008","unstructured":"Wehr, C. et al. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood 111, 77\u201385 (2008).","journal-title":"Blood"},{"key":"1191_CR8","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/S0952-7915(00)00216-8","volume":"13","author":"GA Bishop","year":"2001","unstructured":"Bishop, G. A. & Hostager, B. S. B lymphocyte activation by contact mediated interactions with T lymphocytes. Curr. Opin. Immunol. 13, 278\u2013285 (2001).","journal-title":"Curr. Opin. Immunol."},{"key":"1191_CR9","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1365-2141.2010.08077.x","volume":"149","author":"EG Davies","year":"2010","unstructured":"Davies, E. G. & Thrasher, A. J. Update on the hyper immunoglobulin M syndromes. Br. J. Haematol. 149, 167\u2013180 (2010).","journal-title":"Br. J. Haematol."},{"key":"1191_CR10","doi-asserted-by":"publisher","first-page":"7867","DOI":"10.4049\/jimmunol.175.12.7867","volume":"175","author":"R Ettinger","year":"2005","unstructured":"Ettinger, R. et al. IL-21 induces differentiation of human naive and memory B-cells into antibody-secreting plasma cells. J. Immunol. 175, 7867\u20137879 (2005).","journal-title":"J. Immunol."},{"key":"1191_CR11","doi-asserted-by":"publisher","first-page":"5236","DOI":"10.4049\/jimmunol.177.8.5236","volume":"177","author":"KL Good","year":"2006","unstructured":"Good, K. L., Bryant, V. L. & Tangye, S. G. Kinetics of human B-cell behavior and amplification of proliferative responses following stimulation with IL-21. J. Immunol. 177, 5236\u20135247 (2006).","journal-title":"J. Immunol."},{"key":"1191_CR12","doi-asserted-by":"publisher","first-page":"8180","DOI":"10.4049\/jimmunol.179.12.8180","volume":"179","author":"VL Bryant","year":"2007","unstructured":"Bryant, V. L. et al. Cytokine-mediated regulation of human B-cell differentiation into Ig-secreting cells: predominant role of IL-21 produced by CXCR5+T follicular helper cells. J. Immunol. 179, 8180\u20138190 (2007).","journal-title":"J. Immunol."},{"key":"1191_CR13","doi-asserted-by":"publisher","first-page":"6824","DOI":"10.1182\/blood-2011-06-362533","volume":"118","author":"M Recher","year":"2011","unstructured":"Recher, M. et al. IL-21 is the primary common \u03b3 chain-binding cytokine required for human B-cell differentiation in vivo. Blood 118, 6824\u20136835 (2011).","journal-title":"Blood"},{"key":"1191_CR14","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1084\/jem.20130323","volume":"210","author":"EK Deenick","year":"2103","unstructured":"Deenick, E. K. et al. Naive and memory human B-cells have distinct requirements for STAT3 activation to differentiate into antibody-secreting plasma cells. J. Exp. Med. 210, 2739\u20132753 (2103).","journal-title":"J. Exp. Med."},{"key":"1191_CR15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/cei.12150","volume":"174","author":"A Clemente","year":"2013","unstructured":"Clemente, A., Pons, J., Lanio, N., Matamoros, N. & Ferrer, J. M. CD27+B-cells from a subgroup of common variable immunodeficiency patients are less sensitive to apoptosis rescue regardless of interleukin-21 signalling. Clin. Exp. Immunol. 174, 97\u2013108 (2013).","journal-title":"Clin. Exp. Immunol."},{"key":"1191_CR16","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.4049\/jimmunol.1201678","volume":"190","author":"BB Ding","year":"2013","unstructured":"Ding, B. B., Bi, E., Chen, H., Yu, J. J. & Ye, B. H. IL-21 and CD40L synergistically promote plasma cell differentiation through upregulation of Blimp-1 in human B-cells. J. Immunol. 190, 1827\u20131836 (2013).","journal-title":"J. Immunol."},{"key":"1191_CR17","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.4049\/jimmunol.0803009","volume":"182","author":"D Konforte","year":"2009","unstructured":"Konforte, D., Simard, N. & Paige, C. J. IL-21: an executor of B-cell fate. J. Immunol. 182, 1781\u20131787 (2009).","journal-title":"J. Immunol."},{"key":"1191_CR18","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1097\/ACI.0000000000000009","volume":"13","author":"M Desjardins","year":"2013","unstructured":"Desjardins, M. & Mazer, B. D. B-cell memory and primary immune deficiencies: interleukin-21 related defects. Curr. Opin. Allergy Clin. Immunol. 13, 639\u2013645 (2013).","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"1191_CR19","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jaci.2014.06.022","volume":"135","author":"AL R\u00f6sel","year":"2015","unstructured":"R\u00f6sel, A. L. et al. Classification of common variable immunodeficiencies using flow cytometry and a memory B-cell functionality assay. J. Allergy Clin. Immunol. 135, 198\u2013208 (2015).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1191_CR20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s10875-017-0452-0","volume":"38","author":"M Desjardins","year":"2018","unstructured":"Desjardins, M. et al. Modulation of the interleukin-21 pathway with interleukin-4 distinguishes common variable immunodeficiency patients with more non-infectious clinical complications. J. Clin. Immunol. 38, 45\u201355 (2018).","journal-title":"J. Clin. Immunol."},{"key":"1191_CR21","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/icb.2017.72","volume":"95","author":"EM Carrington","year":"2017","unstructured":"Carrington, E. M. et al. The life and death of immune cell types: The role of BCL-2 antiapoptotic molecules. Immunol. Cell Biol. 95, 870\u2013877 (2017).","journal-title":"Immunol. Cell Biol."},{"key":"1191_CR22","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.semcdb.2017.04.001","volume":"72","author":"RW Birkinshaw","year":"2017","unstructured":"Birkinshaw, R. W. & Czabotar, P. E. The BCL-2 family of proteins and mitochondrial outer membrane permeabilisation. Semin. Cell Dev. Biol. 72, 152\u2013162 (2017).","journal-title":"Semin. Cell Dev. Biol."},{"key":"1191_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj3260001","volume":"326","author":"GM Cohen","year":"1997","unstructured":"Cohen, G. M. Caspases: the executioners of apoptosis. Biochem. J. 326, 1\u201316 (1997).","journal-title":"Biochem. J."},{"key":"1191_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.237","volume":"7","author":"IB Vikstrom","year":"2016","unstructured":"Vikstrom, I. B. et al. MCL-1 is required throughout B-cell development and its loss sensitizes specific B-cell subsets to inhibition of BCL-2 or BCL-XL. Cell Death Dis. 7, e2345 (2016).","journal-title":"Cell Death Dis."},{"key":"1191_CR25","first-page":"141","volume":"263","author":"WG Telford","year":"2004","unstructured":"Telford, W. G., Komoriya, A. & Packard, B. Z. Multiparametric analysis of apoptosis by flow and image cytometry. Methods Mol. Biol. 263, 141\u2013160 (2004).","journal-title":"Methods Mol. Biol."},{"key":"1191_CR26","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.mito.2017.11.005","volume":"41","author":"H Sandoval","year":"2018","unstructured":"Sandoval, H., Kodali, S. & Wang, J. Regulation of B-cell fate, survival, and function by mitochondria and autophagy. Mitochondrion 41, 58\u201365 (2018).","journal-title":"Mitochondrion"},{"key":"1191_CR27","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s10875-006-9001-y","volume":"26","author":"Z Husain","year":"2006","unstructured":"Husain, Z., Holodick, N., Day, C., Szymanski, I. & Alper, C. A. Increased apoptosis of CD20+IgA+B-cells is the basis for IgA deficiency: the molecular mechanism for correction in vitro by IL-10 and CD40L. J. Clin. Immunol. 26, 113\u2013125 (2006).","journal-title":"J. Clin. Immunol."},{"key":"1191_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molimm.2015.12.016","volume":"71","author":"R Yazdani","year":"2016","unstructured":"Yazdani, R. et al. Role of apoptosis in common variable immunodeficiency and selective immunoglobulin A deficiency. Mol. Immunol. 71, 1\u20139 (2016).","journal-title":"Mol. Immunol."},{"key":"1191_CR29","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1172\/JCI59211","volume":"121","author":"J Van Grevenynghe","year":"2011","unstructured":"Van Grevenynghe, J. et al. Loss of memory B-cells during chronic HIV infection is driven by FoxP3a- and TRAIL-mediated apoptosis. J. Clin. Invest. 121, 3877\u20133888 (2011).","journal-title":"J. Clin. Invest."},{"key":"1191_CR30","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/j.1365-2796.2012.02550.x","volume":"272","author":"N Ruffin","year":"2012","unstructured":"Ruffin, N. et al. Immune activation and increased IL-21R expression are associated with the loss of memory B-cells during HIV-1 infection. J. Intern. Med. 272, 492\u2013503 (2012).","journal-title":"J. Intern. Med."},{"key":"1191_CR31","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/cdd.2017.30","volume":"24","author":"EM Carrington","year":"2017","unstructured":"Carrington, E. M. et al. Anti-apoptotic proteins BCL-2, MCL-1 and A1 summate collectively to maintain survival of immune cell populations both in vitro and in vivo. Cell Death Differ. 24, 878\u2013888 (2017).","journal-title":"Cell Death Differ."},{"key":"1191_CR32","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jaci.2016.04.043","volume":"139","author":"B Keller","year":"2017","unstructured":"Keller, B. et al. Disturbed canonical nuclear factor of \u03ba light chain signaling in B-cells of patients with common variable immunodeficiency. J. Allergy Clin. Immunol. 139, 220\u2013231 (2017).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1191_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00251-010-0483-7","volume":"63","author":"B Duvvuri","year":"2011","unstructured":"Duvvuri, B. et al. Altered spectrum of somatic hypermutation in common variable immunodeficiency disease characteristic of defective repair of mutations. Immunogenetics 63, 1\u201311 (2011).","journal-title":"Immunogenetics"},{"key":"1191_CR34","doi-asserted-by":"publisher","first-page":"4089","DOI":"10.1182\/blood-2009-02-207423","volume":"114","author":"S Borte","year":"2009","unstructured":"Borte, S. et al. Interleukin-21 restores immunoglobulin production ex vivo in patients with common variable immunodeficiency and selective IgA deficiency. Blood 114, 4089\u20134098 (2009).","journal-title":"Blood"},{"key":"1191_CR35","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1046\/j.1365-2249.1999.00946.x","volume":"117","author":"J Iglesias","year":"1999","unstructured":"Iglesias, J., Matamoros, N., Raga, S., Ferrer, J. M. & Mila, J. CD95 expression and function on lymphocyte subpopulations in common variable immunodeficiency (CVID); related to increased apoptosis. Clin. Exp. Immunol. 117, 138\u2013146 (1999).","journal-title":"Clin. Exp. Immunol."},{"key":"1191_CR36","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1046\/j.1365-2249.2001.01560.x","volume":"125","author":"M Di Renzo","year":"2001","unstructured":"Di Renzo, M. et al. Enhanced T-cell apoptosis in common variable immunodeficiency: negative role of the fas\/fasligand system and of the Bcl-2 family proteins and possible role of TNF-RS. Clin. Exp. Immunol. 125, 117\u2013122 (2001).","journal-title":"Clin. Exp. Immunol."},{"key":"1191_CR37","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3389\/fimmu.2017.00174","volume":"8","author":"V Cunill","year":"2017","unstructured":"Cunill, V. et al. Follicular T-cells from smB-common variable immunodeficiency patients are skewed toward a Th1 phenotype. Front. Immunol. 8, 174 (2017).","journal-title":"Front. Immunol."},{"key":"1191_CR38","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.clim.2018.09.006","volume":"197","author":"D Turpin","year":"2018","unstructured":"Turpin, D. et al. Increase of follicular helper T-cells skewed toward a Th1 profile in CVID patients with non-infectious clinical complications. Clin. Immunol. 197, 130\u2013138 (2018).","journal-title":"Clin. Immunol."},{"key":"1191_CR39","doi-asserted-by":"publisher","unstructured":"Romberg, N. et al. Patients with common variable immunodeficiency with autoimmune cytopenias exhibit hyperplastic yet inefficient germinal center responses. J. Allergy Clin. Immunol.https:\/\/doi.org\/10.1016\/j.jaci.2018.06.012 (2018).","DOI":"10.1016\/j.jaci.2018.06.012"},{"key":"1191_CR40","doi-asserted-by":"publisher","first-page":"592","DOI":"10.3389\/fimmu.2018.00592","volume":"9","author":"R Liu","year":"2018","unstructured":"Liu, R. et al. Proapoptotic BIM impacts B lymphoid homeostasis by limiting the survival of mature B-cells in a cell-autonomous manner. Front. Immunol. 9, 592 (2018).","journal-title":"Front. Immunol."},{"key":"1191_CR41","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/sj.cdd.4400786","volume":"8","author":"FJ Geske","year":"2001","unstructured":"Geske, F. J., Lieberman, R., Strange, R. & Gerschenson, L. E. Early stages of p53-induced apoptosis are reversible. Cell Death Differ. 8, 182\u2013191 (2001).","journal-title":"Cell Death Differ."},{"key":"1191_CR42","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.4049\/jimmunol.1403001","volume":"194","author":"M Chen","year":"2015","unstructured":"Chen, M., Kodali, S., Jang, A., Kuai, L. & Wang, J. Requeriment for autophagy in the long-term persistence but not initial formation of memory B-cells. J. Immunol. 194, 2607\u20132615 (2015).","journal-title":"J. Immunol."},{"key":"1191_CR43","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cellimm.2011.01.004","volume":"268","author":"A Clemente","year":"2011","unstructured":"Clemente, A., Pons, J., Matamoros, N., Iglesias, J. & Ferrer, J. M. B-cells from common variable immunodeficiency patients fail to differentiate to antibody secreting cells in response to TLR9 ligand (CpG-ODN) or anti-CD40+IL21. Cell Immunol. 268, 9\u201315 (2011).","journal-title":"Cell Immunol."},{"key":"1191_CR44","doi-asserted-by":"publisher","unstructured":"Gardulf, A., Abolhassani, H., Gustafson, R., Eriksson, L. E., Hammarstr\u00f6m, L. Predictive markers for humoral influenza vaccine response in patients with common variable immunodeficiency. J. Allergy Clin. Immunol.https:\/\/doi.org\/10.1016\/j.jaci.2018.02.052 (2018).","DOI":"10.1016\/j.jaci.2018.02.052"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1191-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1191-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1191-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T15:03:12Z","timestamp":1672671792000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1191-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,21]]},"references-count":44,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["1191"],"URL":"https:\/\/doi.org\/10.1038\/s41419-018-1191-8","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,21]]},"assertion":[{"value":"9 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"1156"}}